AbCellera Biologics’ IPO

Goodwin Procter LLP advised AbCellera Biologics Inc. on the deal.

AbCellera Biologics Inc. (Nasdaq: ABCL) announced its initial public offering of 27,772,500 common shares at a price to the public of $20 per share, which includes the exercise in full of the underwriters’ option to purchase 3,622,500 additional common shares. The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, were approximately $555.5 million. In addition, upon the closing of the offering, previously issued convertible promissory notes, with an aggregate principal amount of approximately $90 million, converted into 6,093,524 common shares at a price of $17 per share.

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development.

The Goodwin team was led by Deepa Rich (Picture), Sam Zucker, James Xu, and Mitch Bloom and included Kim De Glossop, Carly Ward, Anitha Anne and Zuza Gruca. The team also included Crescent Chasteen, Grace Wirth, Jeremy Slotnick, Alex Varond, Sarah Wicks, Bryna Shmerling, Dan Karelitz, Josh Lake, Kara Kuritz, Caroline Bullerjahn, and Ettore Santucci with paralegal assistance from Tricia Hojo and Ruowen Li.

Involved fees earner: Anitha Anne – Goodwin Procter; Mitchell Bloom – Goodwin Procter; Caroline Bullerjahn – Goodwin Procter; Crescent Moran Chasteen – Goodwin Procter; Kim de Glossop – Goodwin Procter; Zuzanna Gruca – Goodwin Procter; Daniel Karelitz – Goodwin Procter; Kara Kuritz – Goodwin Procter; Joshua Lake – Goodwin Procter; Deepa Rich – Goodwin Procter; Ettore Santucci – Goodwin Procter; Bryna Shmerling – Goodwin Procter; Jeremy Slotnick – Goodwin Procter; Alexander Varond – Goodwin Procter; Carolyn Ward – Goodwin Procter; Sarah Wicks – Goodwin Procter; Grace Wirth – Goodwin Procter; James Xu – Goodwin Procter; Sam Zucker – Goodwin Procter;

Law Firms: Goodwin Procter;

Clients: AbCellera Biologics Inc.;


Author: Ambrogio Visconti